tirzepatide weight loss efficacy vs semaglutide versus Once Weekly in Patients with Type 2 Diabetes tirzepatide vs semaglutide differences efficacy

Patients taking tirzepatide reached a mean maximum reduction of 14.7% of body weight, or 16.0 kilograms, compared with 10.8%, or 11.6 kilograms, for semaglutide

Both are effective at causing weight loss, but tirzepatide is slightly more effective as it works on two receptors and stimulates insulin in larger amounts than semaglutide

Heres what we see most often with Josie members : Nausea (especially after eating too fast or too much) Bloating or fullness Constipation or looser stools Fatigue, especially in the first 12 weeks Appetite changes (most women eat less without feeling deprived) These usually improve over time, especially with the right dose and support

Oral semaglutide also demonstrated a favorable cardiovascular safety profile, and significant reductions in cardiovascular death and all-cause mortality vs

The broken-down fat is then naturally metabolised and eliminated by the body's lymphatic system